Drug Topics October 2019

Statin regimens may need tweaking to deliver optimal results. 

"I’ve yet to meet a pharmacist who ever had this covered in pharmacy school," writes Kreckel. 

Common collaborations include allergy, antibiotic, and opiate consultations.

What execs and experts think of the future of drug costs.

Approved in May 2019, granted to FoldRx, a subsidiary of Pfizer.

What to expect for these high-dollar drugs.

Drug shortages might be decreasing, but their continued existence is urging the pharmacy industry to maintain its vigilance.

Education can help pharmacists feel more comfortable dispensing care.

What new laws could mean for pharmacies’ role in combatting HIV.

The deal is now official, but the companies have been acting as one for some time.

New and old non-opioid pain management solutions. 

Tips for identifying patients with diabetes who need more direction and help.

Noteworthy diabetes management products and updates making waves this year.

How to help manage two of the most common autoimmune diseases.

The drug comes at a time when antibiotic resistance worries are high. Here’s why it matters.

After last year’s drawn-out flu season, the CDC weighs in on what to expect in 2019-2020

Pharmacies are making the most of tech from automation to big data.

Why is pharmacy work so stressful, and how can pharmacists take care of that stress?

Combination therapy for advance endometrial carcinoma.

Fentanyl, oxymorphone, and hydrocodone face greatest cuts.

Eight pharmacy groups lauded a letter urging the Trump administration to reform direct and indirect remuneration (DIR) fees.

The age indication for some influenza vaccines has been expanded.

Texas pharmacies worked with “runners” to divert prescription opioids to the streets.

New concept offers dental, lab tests, immunizations, and other services.

Number of reported cases hightest since 1992.